SynthesisScientific reports2025

Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis.

Siripong Chayanopparat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.